Literature DB >> 11862505

Double-flash, large-fraction radiation therapy as palliative treatment of malignant superior vena cava syndrome in the elderly.

Federico Lonardi1, Gloria Gioga, Graziella Agus, Manuela Coeli, Franco Campostrini.   

Abstract

Rapid control of symptoms is mandatory in cancer-induced superior vena cava syndrome (SVCS), but older patients often do not tolerate aggressive approaches. In order to maximize symptom relief and minimize treatment-related discomfort of aged patients in poor health we adopted a short-course, large-fraction radiation therapy (RT) schedule. Twenty-three consecutive patients aged over 70 who were suffering from solid-malignancy-related SVCS were enrolled. A total dose of 12 Gy was given in two 6-Gy fractions, 1 week apart, mainly in an out-patient setting. Completion of therapy to give up to 37-40 Gy was planned in the best-responding patients. Symptom relief was experienced by 8 patients as early as 4-5 days after the first fraction. The overall response rate was 87%. Despite some mild systemic side effects (chest pain, fever) reported by 5 patients (22%), overall toxicity was negligible. Short-course, double-flash RT stands as an effective and safe tool in the palliative treatment of malignant SVCS in older patients. Fractions larger than 6 Gy can be avoided in order to minimize side and toxic effects.

Entities:  

Mesh:

Year:  2001        PMID: 11862505     DOI: 10.1007/s00520-001-0313-4

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  6 in total

1.  Symptom relief, prognostic factors, and outcome in patients receiving urgent radiation therapy for superior vena cava syndrome : A single-center retrospective analysis of 21 years' practice.

Authors:  Manuel Guhlich; Teresa Esther Maag; Leif Hendrik Dröge; Rami A El Shafie; Andrea Hille; Sandra Donath; Markus Anton Schirmer; Olga Knaus; Friedemann Nauck; Tobias Raphael Overbeck; Marc Hinterthaner; Wolfgang Körber; Stefan Andreas; Achim Rittmeyer; Martin Leu; Stefan Rieken
Journal:  Strahlenther Onkol       Date:  2022-05-12       Impact factor: 3.621

Review 2.  Malignant Venous Obstruction: Superior Vena Cava Syndrome and Beyond.

Authors:  Tamir Friedman; Keith B Quencer; Sirish A Kishore; Ronald S Winokur; David C Madoff
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

3.  Single-Setting Superior Vena Cava Biopsy and Stenting Utilizing Cone Beam Computed Tomography as an Additional Tool.

Authors:  Daniel Yuxuan Ong; Lawrence Han Hwee Quek; Ivan Kuang Hsin Huang; Gavin Hock Tai Lim; Gabriel Chan; Yi-Wei Wu; Seung Wook Ryu; Uei Pua
Journal:  Am J Case Rep       Date:  2021-03-22

4.  Palliative radiotherapy for superior vena caval obstruction by lung cancer: A major issue about timing and a minor issue about efficacy.

Authors:  Federico Ampil; Gloria Caldito; Carlos Previgliano
Journal:  Ann Thorac Med       Date:  2012-07       Impact factor: 2.219

5.  When Palliative Treatment Achieves More Than Palliation: Instances of Long-term Survival after Palliative Radiotherapy.

Authors:  Madhup Rastogi; Swaroop Revannasiddaiah; Manoj K Gupta; Rajeev K Seam; Priyanka Thakur; Manish Gupta
Journal:  Indian J Palliat Care       Date:  2012-05

Review 6.  Review of evolving etiologies, implications and treatment strategies for the superior vena cava syndrome.

Authors:  Christopher Straka; James Ying; Feng-Ming Kong; Christopher D Willey; Joseph Kaminski; D W Nathan Kim
Journal:  Springerplus       Date:  2016-02-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.